1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

  • July 2015
  • 58 pages
  • GlobalData
Report ID: 3176975

Summary

Table of Contents

Search Inside

EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

Summary

Genital herpes is a chronic, sexually transmitted infection caused by the herpes simplex virus (HSV) and is the primary cause of genital ulcers. Genital herpes can also be vertically transmitted from a mother to her newborn during birth, leading to a high risk of mortality in infants. HSV has two forms: HSV-1 and HSV-2. The majority of genital herpes cases globally are caused by HSV-2, although approximately half of all new cases in developed countries are caused by HSV-1. Most cases of genital herpes are asymptomatic, leading to the diagnosed prevalence being substantially lower than that of the total prevalence. The symptomatic cases of genital herpes are typically characterized by painful blisters on the genitals and surrounding areas, which normally present between four and seven days after sexual contact with another infected individual.

GlobalData epidemiologists forecast an increase in the diagnosed incident cases of genital herpes in the 7MM from 405,319 in 2013 to 448,525 diagnosed incident cases in 2023, at an Annual Growth Rate (AGR) of 1.07% during the forecast period. The distribution of diagnosed incident cases of genital herpes in the 7MM was lower in men (153,129 cases, 37.78% in 2013) than it was in women (252,190 cases, 62.22% in 2013). The diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and HSV-1 and HSV-2 co-infection genital herpes increased from 2013 to 2023 in the 7MM, with respective AGRs of 0.53%, 0.71%, and 0.74%. In all the markets, the diagnosed prevalent cases of genital herpes increased with age, which is reflective of the lifetime infection characteristic of the disease.

GlobalData’s epidemiological forecasts for the diagnosed incident cases and diagnosed prevalent cases of genital herpes are supported by age- and sex-specific data obtained from country-specific studies published in peer-reviewed journals, in which the study populations were representative of the general population in the respective markets. The forecast provides the sex-specific diagnosed incident cases of genital herpes in each of the 7MM and the diagnosed prevalent cases of genital herpes segmented by strain type (HSV-1, HSV-2, and the co-infection of HSV-1 and HSV-2), which facilitate an in-depth understanding of the epidemiological trends and informs strategies to improve the management of the disease.

Scope

- The Genital Herpes EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for genital herpes in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of genital herpes, segmented by strain (HSV-1 and HSV-2) for ages =18 years, and the diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and genital herpes caused by the co-infection of both HSV-1 and HSV-2, segmented by sex for ages =18 years.
- The Genital Herpes epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Genital Herpes EpiCast series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global genital herpes market.
- Quantify patient populations in the global genital herpes market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for genital herpes therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Infectious Disease Testing Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • May 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Virology and Bacteriology Testing Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • June 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Automated Microbiology Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification

  • $ 52500
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.